companies / targtex-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 2,700,0002.7M | ○ |
|---|---|---|
| founded | null | |
| hq | Torres Vedras, Portugal | |
| industry | unknown | |
| stage | null |
TargTex develops localized therapies for glioblastoma, with a lead surgical-adjunct drug targeting an unexplored protein in the tumor. It is built for glioblastoma patients with few treatment options. Its targeted local delivery aims to act as a surgical adjunct rather than a systemic therapy.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2023-07-01 | grant | 2,700,0002.7M | null | ○ |
LiteSpeed, PHP 7.4.33, WordPress 5.2.4, Amazon Web Services, Modernizr, Google Maps, Slider Revolution, Stellar.js, jQuery Migrate, parallax.js, Contact Form 7, MySQL
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |